OpenURL Connection Search

Select item for more details and to access through your institution.

Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer.
Published in:
International Journal of Molecular Sciences, 2022, v. 23, n. 14, p. 7987, doi. 10.3390/ijms23147987
By:
- Doldi, Valentina;
- Lecchi, Mara;
- Ljevar, Silva;
- Colecchia, Maurizio;
- Campi, Elisa;
- Centonze, Giovanni;
- Marenghi, Cristina;
- Rancati, Tiziana;
- Miceli, Rosalba;
- Verderio, Paolo;
- Valdagni, Riccardo;
- Gandellini, Paolo;
- Zaffaroni, Nadia
Publication type:
Article
Secondary primary malignancies after CD‐19 directed CAR‐T‐cell therapy in lymphomas: A report from the Italian CART‐SIE study.
Published in:
British Journal of Haematology, 2024, v. 205, n. 4, p. 1356, doi. 10.1111/bjh.19590
By:
- Barone, Angelica;
- Chiappella, Annalisa;
- Casadei, Beatrice;
- Bramanti, Stefania;
- Ljevar, Silva;
- Chiusolo, Patrizia;
- Di Rocco, Alice;
- Tisi, Maria Chiara;
- Barbui, Anna Maria;
- Farina, Mirko;
- Brunello, Lucia;
- Di Chio, Maria Chiara;
- Novo, Mattia;
- Musso, Maurizio;
- Olivieri, Jacopo;
- Trotta, Gentiana Elena;
- Dodero, Anna;
- Aiello, Antonella;
- Corradini, Paolo
Publication type:
Article
Outcome after chimeric antigen receptor (CAR) T‐cell therapy failure in large B‐cell lymphomas.
Published in:
British Journal of Haematology, 2024, v. 204, n. 1, p. 151, doi. 10.1111/bjh.19057
By:
- Dodero, Anna;
- Bramanti, Stefania;
- Di Trani, Martina;
- Pennisi, Martina;
- Ljevar, Silva;
- Chiappella, Annalisa;
- Massimo, Magagnoli;
- Guidetti, Anna;
- Corrado, Francesco;
- Nierychlewska, Paulina Maria;
- Di Rocco, Alice;
- Lorenzini, Daniele;
- Daoud, Rahal;
- De Philippis, Chiara;
- Santoro, Armando;
- Carlo‐Stella, Carmelo;
- Corradini, Paolo
Publication type:
Article
T‐cell immune response after mRNA SARS‐CoV‐2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies.
Published in:
British Journal of Haematology, 2022, v. 196, n. 3, p. 548, doi. 10.1111/bjh.17877
By:
- Marasco, Vincenzo;
- Carniti, Cristiana;
- Guidetti, Anna;
- Farina, Lucia;
- Magni, Martina;
- Miceli, Rosalba;
- Calabretta, Ludovica;
- Verderio, Paolo;
- Ljevar, Silva;
- Serpenti, Fabio;
- Morelli, Daniele;
- Apolone, Giovanni;
- Ippolito, Giuseppe;
- Agrati, Chiara;
- Corradini, Paolo
Publication type:
Article
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2.
Published in:
Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01510-9
By:
- Pusceddu, Sara;
- Corti, Francesca;
- Prinzi, Natalie;
- Nichetti, Federico;
- Ljevar, Silva;
- Busico, Adele;
- Cascella, Tommaso;
- Leporati, Rita;
- Oldani, Simone;
- Pircher, Chiara Carlotta;
- Coppa, Jorgelina;
- Resi, Veronica;
- Milione, Massimo;
- Maccauro, Marco;
- Miceli, Rosalba;
- Tamborini, Elena;
- Perrone, Federica;
- Spreafico, Carlo;
- Niger, Monica;
- Morano, Federica
Publication type:
Article

Found: 5

Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer.

Secondary primary malignancies after CD‐19 directed CAR‐T‐cell therapy in lymphomas: A report from the Italian CART‐SIE study.

Outcome after chimeric antigen receptor (CAR) T‐cell therapy failure in large B‐cell lymphomas.

T‐cell immune response after mRNA SARS‐CoV‐2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies.

Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2.